Botica3

Botica3 is a Spanish biotechnology company specializing in personalized medicine through the application of pharmacogenetics. The company develops and provides advanced genetic testing services designed to predict how individual patients will respond to specific medications based on their unique genetic profiles. By identifying variations in genes responsible for drug metabolism and response, Botica3 helps clinicians optimize treatment regimens, reduce the risk of adverse drug reactions, and improve overall therapeutic efficacy. Their work primarily supports clinical decision-making in complex fields such as oncology, psychiatry, and cardiology, facilitating the transition toward precision healthcare.